Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial

BACKGROUND: Pharmacological and clinical differences between insulin glargine and NPH insulin may translate into differences in patient reported outcomes, but existing data are equivocal. METHODS: In this 48-week, open-label, randomized, multi-center, crossover phase IV trial, insulin naïve type 2 d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Qual Life Outcomes
Main Authors: Hermanns, Norbert, Kulzer, Bernd, Kohlmann, Thomas, Jacob, Stephan, Landgraf, Wolfgang, Theobald, Karlheinz, Haak, Thomas
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2015
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4459660/
https://ncbi.nlm.nih.gov/pubmed/26055391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-015-0279-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares